Looking For Infliximab Prescription?

Infliximab, or Inflectra, is sometimes mistaken with Inflectra Software

Inflectra® is the brand name of an FDA-approved biosimilar for Remicade® (Infliximab) developed and marketed by Pfizer Inc. Inflectra® is also the brand name of Inflectra Corporation that manufactures the SpiraPlan® agile project management platform, Rapise® codeless test automation product and other software products.

This website belongs to Inflectra Corporation and although we do work with medical companies, we aren't affiliated with the medication, or Pfizer in any way. Please do not contact us regarding the drug as unfortunately we are not able to assist you with those enquires. However we can help you with our Software Products designed to assist customers in the Bio-Med and Life Sciences industries.

Explore Our Software Go Pfizer's Website

More Information

What is Infliximab?

Infliximab is a monoclonal antibody that is used in the treatment of various autoimmune diseases. It works by blocking the action of tumor necrosis factor alpha (TNFα), a substance in the body that causes inflammation and is involved in the immune response. By inhibiting TNFα, infliximab can help reduce inflammation and slow the progression of autoimmune diseases.

Why You Might Take Infliximab

Infliximab is prescribed for several conditions, including:

Rheumatoid arthritis: To reduce signs and symptoms, prevent joint damage, and improve physical function.
Crohn's disease: For the treatment of moderate to severe Crohn's disease in adults and children when other treatments have not worked.
Ulcerative colitis: To treat moderate to severe ulcerative colitis in adults and children when certain other medications haven't worked well enough.
Ankylosing spondylitis: To reduce signs and symptoms.
Psoriatic arthritis: To treat active psoriatic arthritis.
Plaque psoriasis: For the treatment of chronic severe (extensive and/or disabling) plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.

Brand Names of Infliximab

Infliximab is available under several brand names, including:

Remicade: The original and most widely known brand of infliximab.
Inflectra: A biosimilar to Remicade.
Renflexis: Another biosimilar to Remicade.
Ixifi: Also a biosimilar to Remicade, available in certain regions.
Flixabi: Available in some countries, also a biosimilar to Remicade.

Biosimilars are biological products that are highly similar to and have no clinically meaningful differences from an existing FDA-approved reference product. They provide more treatment options and may be more affordable alternatives to existing treatments.

Infliximab is administered through intravenous infusion, typically at a doctor's office or infusion center, and the frequency of treatment varies depending on the condition being treated and the patient's response to therapy.